Table 6.

Reported adverse effects

	Placebo (n = 65) * n (%)	MAG-EPA (n = 63) * n (%)
Diarrhea	1 (1.5)	2 (3.2)
Skin rash	2 (3.1)	1 (1.6)
Nausea	1 (1.5)	3 (4.8)
Digestive problems	1 (1.5)	1 (1.6)
Total patients with events	5 (7.7) **	7 (11.1) **

^*The sample size is greater than for the main Ki-67 analysis as all patients who underwent radical prostatectomy are included. **1 patient in placebo group and 5 patients in MAG-EPA group stopped study supplementation because of adverse effects.

MAG-EPA monoacylglyceride-conjugated eicosapentaenoic acid.